CSIMarket
 
Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 
 


Very steep Reduction at the company in the fiscal time-frame ending September 30 2022

company recorded third quarter of 2022 operating loss of $-29.606 millions

Published 2022-11-08T16:42:52+00:00
Goran Soko / CSIMarket.com Contributer

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_CommonsFor the July to September 30 2022 interval company decreased a loss per share of $-0.58 per share compare to $-0.78 a year before and EPS improved from $-0.59 per share from the prior reporting period.

Revenues dropped sharply by -98.527 % to $0.01 millions from $0.54 millions in the similar reporting period a year before and sequentially Revenue Tumbled by -61.905 % from $0.02 millions.




In the July to September 30 2022 interval Concert Pharmaceuticals Inc reported net shortfall of $-28.904 million, instead of deficit of $-53.356 millions in the similar reporting period a year ago.


Concert Pharmaceuticals Inc is expected to report next financial results on March 02, 2023.


    Recently Reported Results
Post_and_Beam_Barn_Kitchen_By_Vermont_Timber_Works_Inc.__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons China King Spirit Group Ltd

China King Spirit Group Ltd announced operating deficit of $-0.015355 millions, in the first quarter of 2022 financial report

Following the big players in the Forestry & Wood Products sector, a number of overlooked businesses are publishing the earnings. CKSG said it has clinched operating deficit of $-0.015355 millions, for the first quarter of 2022.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities fell in October by -0.1 %

Fed reported declining U.S. Industrial production in October, as the demand for industrial goods softens.

Inside_Store_pd The Children S Place Inc

Revenues regressed, at The Children S Place Inc over the third quarter of 2022

In the most recent fiscal period EPS dropped by -38.49 % to $3.26 per share due to Revenue decrease of -8.797 % to $509.12 millions, year on year.

Production by industry

Capacity utilization by industry

Checkouts_By_Bill_McChesney_from_USA_(8199_Playa_Del_Carmen_WalMart)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Macys Inc

A gradual Reduction in Revenues at Macys Inc amid the third quarter of 2022

For the third quarter of 2022 earnings season Macys Inc income per share plummeted by -48.68 % of $0.39 per share compare to $0.76 a year ago and profit plummeted by -60.61 % from $0.99 per share from the prior reporting period.

Revenues contracted by -3.86 % to $5.23 billions from $5.44 billions in the similar reporting period a year ago and sequentially Revenue decreased by -6.607 % from $5.60 billions.

Production by industry

Capacity utilization by industry

Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Cnbx Pharmaceuticals Inc

The arising company from the Biotechnology & Pharmaceuticals sector the CNBK issued the fiscal interval ending fourth quarter of 2022, results

Trailing the large companies in the Biotechnology & Pharmaceuticals industry, a few overlooked corporations are publishing the respective numbers. CNBK said it has clinched operating deficit of $-0.478354 millions, for the fourth quarter of 2022.

Production by industry

Capacity utilization by industry

Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common